Evaluation and treatment of erectile dysfunction
- PMID: 21095423
- DOI: 10.1016/j.mcna.2010.08.016
Evaluation and treatment of erectile dysfunction
Abstract
Erectile dysfunction (ED) is a prevalent and important disease that has been associated with various comorbidities. The evaluation of patients with ED should include a general health assessment followed by a discussion of reversible factors and lifestyle changes that might help preserve erectile capacity. Numerous effective treatment options are currently available. A frank discussion about use and side effects of these therapies is required to optimize success. Although oral pharmacologic treatments can be initiated and monitored by the primary care physician, patients who do not experience response to these treatments may be best served by referral to a sexual medicine specialist for further assessment and consideration of other treatment options. This article discusses the physiology and pathophysiology of erectile function in men, how the primary care physician may address the clinical problem of ED in practice, and when specialty referral is indicated.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Evaluation and treatment of erectile dysfunction in the aging male: a mini-review.Gerontology. 2012;58(1):3-14. doi: 10.1159/000329598. Epub 2011 Sep 7. Gerontology. 2012. PMID: 21912081
-
Core document on erectile dysfunction: key aspects in the care of a patient with erectile dysfunction.Int J Impot Res. 2004 Oct;16 Suppl 2:S26-39. doi: 10.1038/sj.ijir.3901240. Int J Impot Res. 2004. PMID: 15496854 Review.
-
Erectile Dysfunction.Prim Care. 2019 Jun;46(2):249-255. doi: 10.1016/j.pop.2019.02.006. Epub 2019 Apr 1. Prim Care. 2019. PMID: 31030826 Review.
-
The management of erectile dysfunction in the community.Int J Impot Res. 2001 Aug;13 Suppl 3:S45-51. doi: 10.1038/sj.ijir.3900723. Int J Impot Res. 2001. PMID: 11477492 Review.
-
Recent advances in the understanding and management of erectile dysfunction.F1000Res. 2019 Jan 25;8:F1000 Faculty Rev-102. doi: 10.12688/f1000research.16576.1. eCollection 2019. F1000Res. 2019. PMID: 30740217 Free PMC article. Review.
Cited by
-
Male Sexual Dysfunction.Health Psychol Res. 2022 Aug 20;10(3):37533. doi: 10.52965/001c.37533. eCollection 2022. Health Psychol Res. 2022. PMID: 35999971 Free PMC article.
-
Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis.World J Urol. 2021 Mar;39(3):953-962. doi: 10.1007/s00345-020-03233-9. Epub 2020 May 9. World J Urol. 2021. PMID: 32388784
-
Carotid artery intima media thickness can predict the response to phosphodiesterase 5 inhibitors in patients with moderate erectile dysfunction.Sex Med. 2023 Jul 31;11(3):qfad042. doi: 10.1093/sexmed/qfad042. eCollection 2023 Jun. Sex Med. 2023. PMID: 37529683 Free PMC article. Review.
-
Practical Approaches to Treat ED in PDE5i Nonresponders.Aging Dis. 2020 Oct 1;11(5):1202-1218. doi: 10.14336/AD.2019.1028. eCollection 2020 Oct. Aging Dis. 2020. PMID: 33014533 Free PMC article. Review.
-
Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails.Drugs Aging. 2018 Mar;35(3):175-187. doi: 10.1007/s40266-018-0528-4. Drugs Aging. 2018. PMID: 29464656 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical